Emerging Biopharma

Personalized attention, global expertise

We get that you have a lot at stake. You need a partner who understands your goals, your desire to optimize your asset value, and who can adapt with your team and programs as they move forward.

0056 emerging biopharma

Develop the right evidence generation plan and execute against it with confidence

With ~300 emerging biopharma companies in >500 trials from 2013-2016, our EBP solution is designed to help you confidently deliver credible results to your stakeholders.

Unique challenges deserve a unique solution

As clinical-stage companies, you're focused on progressing your drug candidates for the patients that need them most. With personalized attention and global therapeutic expertise, QuintilesIMS can consistently deliver the comprehensive services you need to confidently drive healthcare forward. We are focused on helping you deliver for today while also providing adaptability for the future of your programs and your growing company.

QuintilesIMS capabilities tailored for your needs

Having worked with more than 300 emerging biopharma companies on over 500 trials from 2013-2016, we've seen firsthand both the benefits and challenges of running a lean organization. We recognize that one of those challenges is finding suitable partners capable of providing both flexibility and access to the capabilities your product and company desire, while aligning to your budget.

Ask us about our new approach for emerging biopharma and how we would tailor our capabilities for your project.



When Entering the Clinic...   +

As your partner, we’ll provide the personalized focus of a niche CRO while delivering the experience and capabilities of a global leader.

Through our integrated Early Clinical Development Platform, we can provide you with the personalized focus and attention of a small CRO with the capabilities of a global service provider to deliver a personalized solution for your Phase I study.

  • Your success is personal to us – We are a focused team of Phase I doctors, nurses, CRAs and other clinical staff in Overland Park, KS and London, UK ready to partner on your project.
  • We partner with you to connect your trial to the capabilities and expertise of a global leader – QuintilesIMS scientific and operational experts will partner with you to design the strongest possible start, providing the insights and high precision data of an industry leader to inform better go/no-go decisions and arrive at a more robust proof-of-concept.

Learn how we worked with an emerging virtual company on a complex protocol, and ultimately became their sole provider.

When Scaling for Drug Development...   +

Access the capabilities and experience you need with the flexibility and personalized service you desire.

Our new model is designed to better meet the needs of our emerging biopharma customers. You’ll receive flexibility and personalized customer service you need…
  • A new tailored operational model – offering the services you need aligned with your budget
  • Focused project leadership – experienced and passionate leaders excited to work with emerging biopharma, who will be your voice within the organization
  • Executive access and governance – from initial engagement through the life of your trial
… while leveraging the scientific and operational capabilities, experience, and scale you desire:
When Planning for Peri- and Post-Marketing Activities...   +

Whether you take your product through commercialization or not, QuintilesIMS can help you optimize its value by incorporating real-world evidence and commercial insights earlier into a commercially-intelligent clinical development plan.

Real World Late Phase Research
Real-world insights are driving healthcare decisions on safety, efficacy, effectiveness and value. To develop the evidence you need to satisfy diverse stakeholders, QuintilesIMS offers therapeutic expertise, real-world data and powerful analytics technology specifically for real-world and late phase research. Large or small, every study is different and calls for its own operational and scientific strategy to fulfill the unique objectives of your programs. 

Satisfy stakeholder demands with a proactive approach. 

commercial solustions thumbnailMarket Access
Increasingly complex healthcare systems and more demanding stakeholders require comprehensive resources and support. QuintilesIMS combines strategic thinking with clinical expertise to effectively demonstrate real-world outcomes, but we don't stop there. Our reach extends to teams in the field who connect with payers on a local level to communicate your product value story.

Leverage QuintilesIMS knowledge of the stakeholder environment and our deep roots in medical and financial analytics, to accelerate, sustain and expand optimal market access for your products. 

Utilize data and insights to navigate the shifting demands of multiple stakeholders

Commercial Launch Solution 
Have you considered maintain the strategic direction of your asset while maximizing its commercial potential? With a comprehensive range of proven commercial services, QuintilesIMS can tailor the right solution to help launch your product or company in any global market.

Learn how QuintilesIMS helped gain significant market penetration for a specialty biopharma company, representing more than 190 million covered lives within one year.

The power of possibilities

Our goal is to help you realize the full potential of your product and your organization. As you grow, we stand beside you to explore the opportunities together.

Related Pages

Q² Solutions: A Quintiles Quest Joint Venture
Advisory Service
Real-World and Late Phase Strategy
Video Spotlights
From Molecule to Market: Deliver Credible Results with Confidence
From Molecule to Market: Deliver Credible Results with Confidence
Partnering with emerging biopharma companies
Partnering with emerging biopharma companies
Quintiles Emerging Biopharma Solution
Quintiles Emerging Biopharma Solution
QuintilesIMS & Emerging Biopharma: The credibility of experience and the power of innovation
QuintilesIMS & Emerging Biopharma: The credibility of experience and the power of innovation

Article Feb 08, 2016
Explore More